SCHEMBL3189384

SCHEMBL3189384

CC1CN(c2cn(S(=O)(=O)c3cccc4c3CCO4)c3cccnc23)CCN1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.36
MTNR1A P48039 6/20 0.34
MTNR1B P49286 6/20 0.34
PRKCQ Q04759 3/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
NFKB1 P19838 1/20 0.34
PRKD3 O94806 1/20 0.34
PRKCG P05129 1/20 0.34
PRKCB P05771 1/20 0.34
PRKCA P17252 1/20 0.34
PRKCH P24723 1/20 0.34
PRKCI P41743 1/20 0.34
PRKCE Q02156 1/20 0.34
PRKCZ Q05513 1/20 0.34
PRKCD Q05655 1/20 0.34
PRKD1 Q15139 1/20 0.34
GHSR Q92847 3/20 0.34
ALOX15 P16050 1/20 0.34
CHEK1 O14757 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3183373 1.00 HTR6 (0.36) HTR6MTNR1AMTNR1BPRKCQCYP3A4
SCHEMBL3173604 1.00 HTR6 (0.36) HTR6MTNR1AMTNR1BPRKCQCYP3A4
SCHEMBL3627280 0.88 HTR6 (0.45) HTR6CYP3A4NFKB1TSHR
SCHEMBL3169009 0.83 HTR6 (0.35) HTR6PRKCQCYP3A4CYP2D6NFKB1
SCHEMBL3168233 0.83 HTR6 (0.35) HTR6PRKCQCYP3A4CYP2D6NFKB1
SCHEMBL3185525 0.83 HTR6 (0.35) HTR6PRKCQCYP3A4CYP2D6NFKB1
SCHEMBL3221756 0.82 HTR6 (0.35) HTR6MTNR1AMTNR1BALOX15
SCHEMBL3221335 0.82 PDCD1 (0.35) HTR6MTNR1AMTNR1BALOX15
SCHEMBL3217661 0.82 MTNR1A (0.41) MTNR1AMTNR1BALOX15
SCHEMBL3215142 0.82 HTR6 (0.39) HTR6MTNR1AMTNR1BALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016297-A1 ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-01-21 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016297-A1 ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR3B, HTR3A HTR6 1/4885MTNR1A 58/4885MTNR1B 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.